SCHEMBL11071289

SCHEMBL11071289

CCNc1ccc(C(=O)OC)cc1C(=O)C(=O)OC(=O)C(=O)c1cc(C(=O)OC)ccc1NCC

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 15/20 0.45
ALDH1A1 P00352 12/20 0.45
MAPT P10636 5/20 0.45
HPGD P15428 5/20 0.45
KMT2A Q03164 2/20 0.43
GAA P10253 4/20 0.42
THRB P10828 1/20 0.42
HTT P42858 1/20 0.42
GFER P55789 1/20 0.42
PLEC Q15149 1/20 0.42
HSD17B10 Q99714 5/20 0.42
LMNA P02545 2/20 0.42
GLA P06280 2/20 0.42
ATM Q13315 2/20 0.42
CASP1 P29466 1/20 0.42
CASP7 P55210 1/20 0.42
CA12 O43570 1/20 0.41
CA1 P00915 1/20 0.41
CA2 P00918 1/20 0.41
CA7 P43166 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11065600 0.85 KDM4E (0.41) KDM4EALDH1A1MAPTHPGDKMT2A
SCHEMBL11063693 0.84 HCAR3 (0.41) KDM4EALDH1A1MAPTHPGDKMT2A
SCHEMBL11068685 0.83 HSD17B3 (0.41) KDM4EALDH1A1MAPTHPGDKMT2A
SCHEMBL22097615 0.77 KDM4E (0.66) KDM4EALDH1A1MAPTHPGDKMT2A
SCHEMBL11066299 0.76 ALDH1A1 (0.58) KDM4EALDH1A1MAPTHPGDKMT2A
SCHEMBL1543144 0.76 GAA (0.71) KDM4EALDH1A1MAPTHPGDGAA
SCHEMBL11068912 0.75 METAP2 (0.45) ALDH1A1HPGDHSD17B10LMNA
SCHEMBL9402430 0.73 ALDH1A1 (0.65) KDM4EALDH1A1MAPTHPGDKMT2A
SCHEMBL2014323 0.73 LNPEP (0.56) KDM4EALDH1A1MAPTHPGDKMT2A
SCHEMBL22415248 0.72 ALDH1A1 (0.48) KDM4EALDH1A1MAPTHPGDKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4476132-A Acylquinolinone derivatives, and antiallergic preparations and methods of inhibiting allergic reactions using them CIBA-GEIGY CORPORATION (US) 1984-10-09 US disclosed